Literature DB >> 23119102

Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.

Abbas Agaimy1, Nikolaos Vassos, Roland S Croner.   

Abstract

Neurofibromatosis type 1 (NF-1, Recklinghausen disease) is the most common hereditary multitumor syndrome with an incidence at birth of approximately 1:3000. However, the significant variation in the expression of the disease not infrequently precludes early diagnosis. As a consequence of non-familiarity with their frequency and wide clinicopathological spectrum, gastrointestinal manifestations of NF-1 are seldom thought of in routine clinical practice and might thus be significantly under-recognized. Their heterogeneous spectrum ranges from localized microscopic proliferative lesions of autonomic nerves and interstitial cells of Cajal and diffuse microscopic ganglio/neuro/fibromatosis to grossly recognizable mass-forming neurofibromas and gastrointestinal stromal tumors (GIST). Furthermore, neuroendocrine neoplasms, particularly of the periampullary duodenum seem to be quite characteristic of this disease. Based on our own experience and the available literature, this review summarizes and discusses the clinicopathological spectrum of gastrointestinal manifestations of NF-1 including putative proliferative precursor lesions with emphasis on the differential diagnostic aspects of these disorders and their molecular pathogenesis. In addition, this review underlines the great value of specific gastrointestinal findings in uncovering undiagnosed or missed NF-1 cases.

Entities:  

Keywords:  GIST; Gastrointestinal stromal tumor; NF-1; Neuroendocrine tumor; Neurofibromatosis; Recklinghausen disease

Mesh:

Year:  2012        PMID: 23119102      PMCID: PMC3484498     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  52 in total

1.  Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).

Authors:  Ludwine Messiaen; Julia Vogt; Kathrin Bengesser; Chuanhua Fu; Fady Mikhail; Eduard Serra; Carles Garcia-Linares; David N Cooper; Conxi Lazaro; Hildegard Kehrer-Sawatzki
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

2.  Surgical management of abdominal manifestations of type 1 neurofibromatosis: experience of a single center.

Authors:  Giuseppe Cavallaro; Ursula Basile; Andrea Polistena; Sandra Giustini; Rossella Arena; Alessandro Scorsi; Laura Zinnamosca; Claudio Letizia; Stefano Calvieri; Giorgio De Toma
Journal:  Am Surg       Date:  2010-04       Impact factor: 0.688

3.  Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours.

Authors:  H Chen; S Hirota; K Isozaki; H Sun; A Ohashi; K Kinoshita; P O'Brien; L Kapusta; I Dardick; T Obayashi; T Okazaki; Y Shinomura; Y Matsuzawa; Y Kitamura
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases.

Authors:  M Miettinen; K M Shekitka; L H Sobin
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

5.  Peripheral nerve sheath tumors of the gastrointestinal tract: a multicenter study of 58 patients including NF1-associated gastric schwannoma and unusual morphologic variants.

Authors:  Abbas Agaimy; Bruno Märkl; Julia Kitz; Peter H Wünsch; Hans Arnholdt; Laszlo Füzesi; Arndt Hartmann; Runjan Chetty
Journal:  Virchows Arch       Date:  2010-02-13       Impact factor: 4.064

6.  Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.

Authors:  Anthony J Gill; Angela Chou; Ricardo Vilain; Adele Clarkson; Millie Lui; Richard Jin; Vivienne Tobias; Jaswinder Samra; David Goldstein; Celia Smith; Loretta Sioson; Nicole Parker; Ross C Smith; Mark Sywak; Stan B Sidhu; Jenny Ma Wyatt; Bruce G Robinson; Robert P Eckstein; Diana E Benn; Roderick J Clifton-Bligh
Journal:  Am J Surg Pathol       Date:  2010-05       Impact factor: 6.394

Review 7.  Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease).

Authors:  C E Fuller; G T Williams
Journal:  Histopathology       Date:  1991-07       Impact factor: 5.087

Review 8.  Multiple gastrointestinal stromal tumors and bilateral pheochromocytoma in neurofibromatosis.

Authors:  Klaus Kramer; Cornelia Hasel; Andrik J Aschoff; Doris Henne-Bruns; Peter Wuerl
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

Review 9.  Diffuse ganglioneuromatosis in small intestine associated with neurofibromatosis type 1.

Authors:  Khin Thway; Cyril Fisher
Journal:  Ann Diagn Pathol       Date:  2007-10-24       Impact factor: 2.090

10.  Ganglioneuromas of the gastrointestinal tract. Relation to Von Recklinghausen disease and other multiple tumor syndromes.

Authors:  K M Shekitka; L H Sobin
Journal:  Am J Surg Pathol       Date:  1994-03       Impact factor: 6.394

View more
  51 in total

1.  Chronic Constipation Caused by Neurofibromatous Proliferation in A Case of Von Recklinghausen's Disease - A Case Report.

Authors:  Honnappa Sridhar; Rau R Aarathi; Mysorekar Vijaya; Jalihal Umesh
Journal:  J Clin Diagn Res       Date:  2013-09-10

2.  Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.

Authors:  James D Murphy; Grace L Ma; Joel M Baumgartner; Lisa Madlensky; Adam M Burgoyne; Chih-Min Tang; Maria Elena Martinez; Jason K Sicklick
Journal:  Cancer       Date:  2015-04-30       Impact factor: 6.860

Review 3.  [Soft tissue tumors in hereditary tumor syndromes].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

4.  Neuroendocrine carcinoma of the gall bladder in a young lady presenting with upper abdominal heaviness: a common complaint and a rare diagnosis.

Authors:  Deep Chakrabarti; Sumaira Qayoom; Arunima Ghosh; Rajeev Gupta
Journal:  BMJ Case Rep       Date:  2019-04-05

5.  Health Survey of Adults with Neurofibromatosis 1 Compared to Population Study Controls.

Authors:  Krister W Fjermestad; Livø Nyhus; Øivind J Kanavin; Arvid Heiberg; Lise B Hoxmark
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

Review 6.  Clinical Presentation of Gastrointestinal Stromal Tumors.

Authors:  Franka Menge; Jens Jakob; Bernd Kasper; Armand Smakic; Timo Gaiser; Peter Hohenberger
Journal:  Visc Med       Date:  2018-10-13

7.  Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs.

Authors:  Sabrina Rossi; Daniela Gasparotto; Matilde Cacciatore; Marta Sbaraglia; Alessia Mondello; Maurizio Polano; Alessandra Mandolesi; Alessandro Gronchi; David E Reuss; Andreas von Deimling; Roberta Maestro; Angelo Paolo Dei Tos
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

8.  Soft tissue perineurioma and other unusual tumors in a patient with neurofibromatosis type 1.

Authors:  Inga-Marie Schaefer; Philipp Ströbel; Aung Thiha; Jan Martin Sohns; Christian Mühlfeld; Stefan Küffer; Gunther Felmerer; Adam Stepniewski; Silke Pauli; Abbas Agaimy
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 9.  Neurofibromatosis: A Review of NF1, NF2, and Schwannomatosis.

Authors:  Jesse Lee Kresak; Meggen Walsh
Journal:  J Pediatr Genet       Date:  2016-03-09

Review 10.  Syndrome-Associated Tumors by Organ System.

Authors:  Raul S Gonzalez; Nicole D Riddle
Journal:  J Pediatr Genet       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.